Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Double-Blind, Placebo-Controlled, Monotherapy Study of Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease

NCT00867828 is registered in ClinicalTrials.gov with NeuroBioPharm Inc. as lead sponsor.

NCT NCT00867828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Double-Blind, Placebo-Controlled, Monotherapy Study of Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease
Lead sponsor
NeuroBioPharm Inc.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
January 31, 2011
Enrollment
175 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

early onset alzheimer disease